In addition to the genes listed above, we considered it worthwhile to also include the uncoupling protein 2 gene (UCP2) in the analysis because some studies have associated a polymorphism in the promoter of the gene (UCP2 −866G>A) with increased risk of T2D and impaired insulin secretion [24–27], whereas other studies have reported reduced risk of T2D [28]. This evidence concerns the gene UCP2 and type 2 diabetes mellitus.